Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ.

AJR Am J Roentgenol. 2001 Jul;177(1):229-36.

PMID:
11418435
2.

Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT.

Kumar J, Seith A, Kumar A, Sharma R, Bakhshi S, Kumar R, Agarwala S.

Pediatr Radiol. 2008 Sep;38(9):953-62. doi: 10.1007/s00247-008-0921-y.

PMID:
18636251
3.

FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.

Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O.

Eur J Nucl Med. 2000 Sep;27(9):1305-11.

PMID:
11007511
4.

Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.

Hahn S, Heusner T, Kümmel S, Köninger A, Nagarajah J, Müller S, Boy C, Forsting M, Bockisch A, Antoch G, Stahl A.

Acta Radiol. 2011 Nov 1;52(9):1009-14. doi: 10.1258/ar.2011.100507.

PMID:
21969709
5.

"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?

Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G.

Eur J Radiol. 2011 Jun;78(3):430-5. doi: 10.1016/j.ejrad.2009.10.031.

PMID:
19945240
6.

Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.

Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.

J Med Imaging Radiat Oncol. 2013 Jun;57(3):297-305. doi: 10.1111/1754-9485.12020.

PMID:
23721138
7.

Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.

Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.

Acta Radiol. 2016 Jan;57(1):58-65. doi: 10.1177/0284185114564438.

PMID:
25533313
9.

Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.

Nakamoto Y, Osman M, Wahl RL.

Clin Nucl Med. 2003 Apr;28(4):302-7.

PMID:
12642709
10.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
11.

Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.

Ito S, Kato K, Ikeda M, Iwano S, Makino N, Tadokoro M, Abe S, Nakano S, Nishino M, Ishigaki T, Naganawa S.

J Nucl Med. 2007 Jun;48(6):889-95.

12.

Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.

Fujimoto R, Higashi T, Nakamoto Y, Hara T, Lyshchik A, Ishizu K, Kawashima H, Kawase S, Fujita T, Saga T, Togashi K.

Ann Nucl Med. 2006 Jul;20(6):399-408.

PMID:
16922468
13.

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H.

J Clin Oncol. 2007 Dec 1;25(34):5435-41.

PMID:
18048826
14.

Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis.

Liu NB, Zhu L, Li MH, Sun XR, Hu M, Huo ZW, Xu WG, Yu JM.

Asian Pac J Cancer Prev. 2013;14(6):3647-52.

15.

Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.

Mosavi F, Johansson S, Sandberg DT, Turesson I, Sörensen J, Ahlström H.

AJR Am J Roentgenol. 2012 Nov;199(5):1114-20. doi: 10.2214/AJR.11.8351.

PMID:
23096187
16.
17.

18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.

Samarin A, Hüllner M, Queiroz MA, Stolzmann P, Burger IA, von Schulthess G, Veit-Haibach P.

Nucl Med Commun. 2015 Dec;36(12):1165-73. doi: 10.1097/MNM.0000000000000387.

PMID:
26397999
18.
19.

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.

Györke T, Zajic T, Lange A, Schäfer O, Moser E, Makó E, Brink I.

Nucl Med Commun. 2006 Jan;27(1):17-24.

PMID:
16340719
20.

Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm.

Pezeshk P, Sadow CA, Winalski CS, Lang PK, Ready JE, Carrino JA.

Acad Radiol. 2006 Aug;13(8):1011-5.

PMID:
16843854
Items per page

Supplemental Content

Support Center